BPEA to Invest USD100m in Chinese Drug Developer HutchMed
Source(s): DealStreetAsia
Baring Private Equity Asia has agreed to invest USD100m in US- and London-listed Hutchison China MediTech (HutchMed), a China-based cancer drug developer. Read more
Source(s): DealStreetAsia
Baring Private Equity Asia has agreed to invest USD100m in US- and London-listed Hutchison China MediTech (HutchMed), a China-based cancer drug developer. Read more